glaxo aim high profit fall glaxosmithkline saw profit fall last year europe big drugmaker say recovery way cheap copy drug particularly paxil wellbutrin weak dollar hit profit global sale firm confident new drug pipeline deliver profit despite failure obesity drug chief executive garnier say difficult year early afternoon trade london company share price penny mr garnier say company absorb lost sale generic still manage grow business continue success key product mean look forward good performance say also important year term research development pipeline progress however firm discontinue development experimental treatment obesity know disappointing clinical trial result glaxo rely new treatment condition cancer diabetes depression allergy lift pace sale growth several disappointing year